𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Mcl-1 and anticancer vaccination: identification of an HLA-A2-restricted epitope

✍ Scribed by Andersen, R S; Wenandy, L; Sørensen, R B; thor Straten, P; Andersen, M H

Book ID
110058446
Publisher
Nature Publishing Group
Year
2007
Tongue
English
Weight
84 KB
Volume
22
Category
Article
ISSN
0887-6924

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Inducible Hsp70 as target of anticancer
Inducible Hsp70 as target of anticancer immunotherapy: Identification of HLA-A*0201-restricted epitopes
✍ Olivier Faure; Stéphanie Graff-Dubois; Laurent Bretaudeau; Laurent Derré; David- 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 French ⚖ 259 KB

## Abstract The design of a broad application tumor vaccine requires the identification of tumor antigens expressed in a majority of tumors of various origins. We questioned whether the major stress‐inducible heat shock protein Hsp70 (also known as Hsp72), a protein frequently overexpressed in huma

Identification of a sperm protein 17 CTL
Identification of a sperm protein 17 CTL epitope restricted by HLA-A1
✍ Maurizio Chiriva-Internati; Zhiqing Wang; Stephanie Pochopien; Emanuela Salati; 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 French ⚖ 70 KB

## Abstract Sperm protein 17 (Sp17) is a novel cancer‐testis antigen. We previously reported the successful generation of Sp17‐specific HLA‐A1‐restricted cytotoxic T‐lymphocytes (CTLs) from the peripheral blood of a healthy donor using a recombinant Sp17 protein. These CTLs were able to kill not on

Identification of a new HLA-A*0201-restr
Identification of a new HLA-A*0201-restricted cryptic epitope from CYP1B1
✍ Britta Maecker; Michael S. von Bergwelt-Baildon; David H. Sherr; Lee M. Nadler; 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 French ⚖ 100 KB

## Abstract Cytochrome P450 1B1 (CYP1B1) was recently shown to be a candidate tumor antigen broadly expressed in solid and hematologic malignancies. Nevertheless, use of such self‐antigens as targets for immune intervention can be limited because of loss of high‐avidity T cells during negative sele